Variability in lung cancer response to ALK inhibitors cannot be explained by the diversity of ALK fusion variants

Natalia V Mitiushkina1, Vladislav I Tiurin1, Aglaya G Iyevleva2

  • 1N.N. Petrov Institute of Oncology, St.-Petersburg, Pesochny, Leningradskaya 68, 197758, Russia.

Biochimie
|August 3, 2018
PubMed

Insights

Distinct anaplastic lymphoma kinase (ALK) fusion variants in non-small cell lung cancer (NSCLC) show similar responses to ALK tyrosine kinase inhibitors (TKIs). This suggests variant type does not impact treatment effectiveness for ALK-rearranged NSCLC patients.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Anaplastic lymphoma kinase (ALK) translocations are key drivers in a subset of non-small cell lung cancer (NSCLC).
  • Preclinical data suggest varying biochemical properties and inhibitor responsiveness among different ALK fusion variants.
  • Clinical evidence is emerging regarding differential responses to ALK tyrosine kinase inhibitors (TKIs) based on specific ALK variants.

Purpose of the Study:

  • To investigate the clinical impact of distinct anaplastic lymphoma kinase (ALK) translocation variants on treatment outcomes in patients with ALK-rearranged non-small cell lung cancer (NSCLC).
  • To compare the efficacy of crizotinib, ceritinib, and alectinib across different ALK fusion variants.

Main Methods:

  • Retrospective analysis of 64 Russian patients with ALK-rearranged NSCLC treated with crizotinib, ceritinib, or alectinib.
  • Genotyping of ALK fusion variants using polymerase chain reaction (PCR).
  • Comparison of progression-free survival (PFS) and objective response rates (ORR) between different ALK variant groups.

Main Results:

  • No significant differences in median PFS or ORR were observed between patients with 'short' (v.3a/b, v.5a/b) versus 'long' (TAPE-domain containing) ALK fusion variants.
  • Similarly, EML4/ALK variant 1 showed comparable outcomes to other ALK translocations regarding PFS and ORR.
  • ALK variants did not influence outcomes when analyzed separately for crizotinib and ceritinib treatments.
  • Ceritinib demonstrated significantly longer PFS compared to crizotinib (p=0.022).

Conclusions:

  • Distinct anaplastic lymphoma kinase (ALK) translocation variants exhibit similar clinical responsiveness to ALK tyrosine kinase inhibitors (TKIs) in non-small cell lung cancer (NSCLC).
  • Treatment outcomes were not significantly influenced by the specific ALK fusion variant.
  • Ceritinib showed superior efficacy over crizotinib in this patient cohort.

Related Concept Videos

Diversity in Cell Signaling Responses01:22

Diversity in Cell Signaling Responses

The physiological function of a cell and cellular communication are outcomes of a range of extrinsic signals, intracellular signaling pathways, and cellular responses. No two cell types express the same repertoire of signaling components. Receptors are highly selective for their cognate ligands, but once activated, they can alter multiple cellular processes such as DNA transcription, protein synthesis, and metabolic activity. 
Graded and Abrupt Responses
Some signaling systems generate...
8.0K
Nuclear Fusion02:45

Nuclear Fusion

The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
33.9K
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.1K
Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
11.0K
Variability: Analysis01:11

Variability: Analysis

Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
522
Random Variables01:09

Random Variables

A random variable is a single numerical value that indicates the outcome of a procedure. The concept of random variables is fundamental to the probability theory and was introduced by a Russian mathematician, Pafnuty Chebyshev, in the mid-nineteenth century.
Uppercase letters such as X or Y denote a random variable. Lowercase letters like x or y denote the value of a random variable. If X is a random variable, then X is written in words, and x is given as a number.
For example, let X = the...
17.9K